A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy

Genomics

Volumn 90, Issue 2, 2007, Pages 261-264

  Meurs, Kathryn M ^a   Norgard, Michelle M ^a   Ederer, Martina M ^a   Hendrix, Kristina P ^a   Kittleson, Mark D ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac; Feline; Hypertrophic cardiomyopathy; Myosin binding protein C

Indexed keywords

ARGININE; MYOSIN BINDING PROTEIN C; TRYPTOPHAN;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CATS; DISEASE MODELS, ANIMAL; DNA, RECOMBINANT; EXONS; MOLECULAR SEQUENCE DATA; POINT MUTATION;

ANIMALIA; FELIDAE;

EID: 34447108243     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2007.04.007     Document Type: Article

References (24)

1. Marian A.J., and Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 33 (2000) 655-670
2. Moolman J.A., et al. A newly created splice donor site in exon 25 of the MYBPC gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation 101 (2000) 1396-1402
3. Bashyam M.D., Savithri G.R., Kumar M.S., Narasimhan C., and Nallari P. Molecular genetics of familial hypertrophic cardiomyopathy. J. Hum. Genet. 48 (2003) 55-64
4. Thierfelder L., Watkins H., and MacRae C. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77 (1994) 701-712
5. Poetter K., et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13 (1996) 63-69
6. Kimura A., et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16 (1997) 379-382
7. Carrier L., et al. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circulation 80 (1997) 427-434
8. Richard P., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnostic strategy. Circulation 107 (2003) 2227-2232
9. Kittleson M.D. Feline myocardial disease. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of Veterinary Internal Medicine (2005), Elsevier, St. Louis 1082-1103
10. Ho C.Y., and Seidman C.E. A contemporary approach to hypertrophic cardiomyopathy. Circulation 113 (2006) e858-e862
11. Meurs K.M., et al. A cardiac myosin binding protein C mutation in the Maine coon cat with familial hypertrophic cardiomyopathy. Hum. Mol. Genet. 14 (2005) 3587-3593
12. Lefbom B.K., et al. Severe hypertrophic cardiomyopathy in 10 young ragdoll cats. J. Vet. Intern. Med. 15 (2001) 308
13. Pugnetti G. Ragdoll cat. In: Siegal M. (Ed). Simon & Schuster's Guide to Cats (1983), Simon & Schuster, New York 10
14. Oakley C.E., Hambley B.D., Curmi P.M.G., and Brown L.G. Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy. Cell Res. 14 (2004) 95-100
15. Witt C., et al. Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin binding protein-C. J. Biol. Chem. 276 (2000) 5353-5359
16. Squire J.M., Luther P.K., and Knupp C. Structural evidence for the interaction of C-protein (MYBP-C) with actin and sequence identification of a possible actin-binding domain. J. Mol. Biol. 331 (2003) 713-724
17. Flavigny J., et al. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J. Mol. Biol. 294 (1999) 443-456
18. Van Driest S.L., et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 1903-1910
19. Nanni L., et al. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 309 (2003) 391-398
20. Cardim N., et al. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin binding protein C gene. Rev. Port. Cardiol. 24 (2005) 1463-1476
21. Jaaskelainen P., et al. Mutations in the cardiac myosin binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. J. Mol. Med. 80 (2002) 412-422
22. Moolman-Smook J., et al. Identification of novel interactions between domains of myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations. Circ. Res. 91 (2002) 704-711
23. Rozen S., and Skaletsky H.J. Primer 3 on the WWW for general users and for biologist programmers. In: Krawetz S.A., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totawa, NJ 365-386
24. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30 (2002) 3894-3900